Beta-Defensin 2 vs Pexiganan — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Human beta-defensin 2 (HBD-2) is an inducible antimicrobial peptide expressed by skin keratinocytes, respiratory epithelium, and gut epithelium in response to microbial infection and pro-inflammatory cytokines. Unlike the constitutively expressed HBD-1, HBD-2 expression is strong...
Calculate Beta-Defensin 2 dose →Pexiganan (MSI-78) is a synthetic analog of magainin-2, optimized for enhanced broad-spectrum antimicrobial activity and reduced hemolytic toxicity. It was developed by Magainin Pharmaceuticals (later Genaera) as a topical treatment for mildly infected diabetic foot ulcers....
Calculate Pexiganan dose →| Parameter | Beta-Defensin 2 | Pexiganan |
|---|---|---|
| Category | Antimicrobial Peptide | Antimicrobial Peptide |
| Research | Preclinical | Phase 3 (Failed 1999) |
| Half-Life | Hours (in tissues) | Hours (topical) |
| Typical Dose | N/A | 0.8% cream topically |
| Frequency | N/A | Twice daily |
| Route | Endogenous (inducible epithelial) / Topical (research) | Topical cream |
| FDA Status | Not approved | Not approved (failed Phase 3) |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.